Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)

Clinical trial NCT01888952 · COMPLETED

Trial details

NCT number

NCT01888952

Sponsor

Anand B. Karnad

Status

COMPLETED

Phase

Early Phase 1

Study type

INTERVENTIONAL

Start date

2013-07-01

Primary completion

2015-01-01

Enrollment

10

View on ClinicalTrials.gov